MedPath

Effect of sharbat aftimoon and qairooti arad karasna on fibroadenosis

Not Applicable
Not yet recruiting
Conditions
Health Condition 1: N602- Fibroadenosis of breast
Registration Number
CTRI/2024/03/064358
Lead Sponsor
department of jarahat
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

presence of breast lump with and without pain.

positive findings of cytological investigations by FNAC

BI-RADS 2nd & 3rd stage

BI-RADS Gradings: stage 1; Negative / Normal

stage 2; Non-cancerous abnormality

stage 3; probably benign

stage 4; suspicious

stage 5; high suggestive of a malignancy

stage 6; biopsy proven malignancy

Exclusion Criteria

Pregnancy and lactation

patient having any systemic disease

BI-RADS 1,4,5,6

breast abscess

PCOS

Patients with history of hormonal treatment for 3 month (OCPS /tamoxifen)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
improvement in pain & tendernessTimepoint: Once weekly for first month then every 15 day for next 2 month.
Secondary Outcome Measures
NameTimeMethod
Decrease the size & symptom of fibroadenosisTimepoint: Before starting the trial & after completing the trial
© Copyright 2025. All Rights Reserved by MedPath